Nezefib (Dexamethasone Sodium Phosphate, Chloramphenicol)

Dexamethasone sodium phosphate, the active ingredient in Nezefib, is a corticosteroid presented as a combination ophthalmic preparation for ocular use. It is combined with chloramphenicol to treat bacterial eye infections and inflammatory ocular conditions.\n\nGNH India supplies Nezefib as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nezefib, a corticosteroid‑antibiotic ophthalmic preparation, is used to manage inflammatory and bacterial eye conditions.\n\n- Bacterial conjunctivitis: reduces bacterial load and alleviates symptoms.\n- Inflammatory ocular conditions (e.g., uveitis, iritis): suppresses inflammation and prevents tissue damage.\n- Post‑operative eye inflammation: controls swelling and prevents infection after eye surgery.

Nezefib may cause ocular and systemic adverse reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Transient burning or stinging on instillation\n- Mild eye irritation or redness\n- Temporary blurred vision\n- Increased intra‑ocular pressure in susceptible patients\n\nSerious or Rare Side Effects:\n- Secondary ocular infection or fungal overgrowth\n- Allergic contact dermatitis of the eyelid\n- Severe elevation of intra‑ocular pressure leading to glaucoma\n- Systemic hypersensitivity reactions (rare)

Nezefib should be used with caution in certain patient groups and situations.\n\n- Pregnancy: safety not established; use only if benefits outweigh risks.\n- Breastfeeding: unknown; consider potential risk to infant.\n- Existing ocular infection: assess bacterial susceptibility before use.\n- Patients with glaucoma or ocular hypertension: monitor intra‑ocular pressure closely.\n- Concurrent use of other corticosteroid eye drops: avoid additive steroid effect.\n- Store at room temperature (≤25°C): keep in original container, protect from light and moisture.

Nezefib can interact with other ophthalmic agents and systemic drugs.\n\nMajor Interactions (Avoid):\n- Systemic corticosteroids: additive immunosuppression and increased infection risk.\n- Topical NSAIDs or other anti‑inflammatory eye drops: heightened risk of corneal melting.\n\nModerate Interactions (Monitor Closely):\n- Anticholinergic eye drops: may reduce tear production, increasing irritation.\n- Beta‑blocker eye drops: possible additive intra‑ocular pressure lowering effect.\n- Other ophthalmic antibiotics: risk of antagonistic bacterial resistance patterns.